MedTrace Logo

Development & Clinical Application of K-PaC Registry Version 2.0

NCT07171515 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 6923

Last updated 2025-09-12

No results posted yet for this study

Summary

Development and clinical use of pancreatic cancer registry

* Development of K-PaC Registry v.2.0: Retrospective data integration from 2010 to 2022 and prospective data collection from more than 811 enrolled patients from 2023 to 2029
* Creation of clinical evidence (RWE) based on pancreatic cancer real-world data (RWD): 3 or more

Conditions

Sponsors & Collaborators

  • National Cancer Center, Korea

    lead OTHER_GOV

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-02
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07171515 on ClinicalTrials.gov